National Institutes of Health

Eolas Therapeutics Announce Initiation of a Phase I Clinical Trial for AZD4041, an Orexin-1 Receptor Antagonist for Smoking Cessation | PRWeb | 12/5/2019

… AstraZeneca. AZD4041 is being developed in partnership with the Blueprint Neurotherapeutics (BPN) Network and with substantial support from the National Institute on Drug Abuse (NIDA) under grant number U01NS083614. The BPN network is a National Institutes of Health (NIH) initiative managed by the National Institute of Neurological Disorders and Stroke (NINDS) that provides non-dilutive support for small molecule drug discovery and development. Healthy volunteers will be treated initially with …

Vedanta Biosciences Awarded $5.8 Million CARB-X Grant to Accelerate Development of VE707 for Multi-Drug Resistant Infections | Business Wire | 12/5/2019

… improve health globally, Germany’s Federal Ministry of Education and Research (BMBF) , the Bill & Melinda Gates Foundation , and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID) , part of the U.S. National Institutes of Health (NIH). A non-profit partnership, CARB-X is investing up to $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines, and rapid diagnostics. CARB-X supports the world’s largest …

Follow National Institutes of Health:    

Permanent hair dyes, chemical straighteners to linked to increased risk of breast cancer, study find | 12/5/2019

… a 9% higher risk of breast cancer, while black women had a 45% increased risk. An 18% higher risk was seen among women who used chemical straighteners. The study, conducted by researchers from the National Institutes of Health and the University of North Carolina-Chapel Hill, was published this week in the International Journal of Cancer. “Our findings do suggest that women should consider their use of hair products in …

Study: Hair dyes, chemical straighteners may increase breast cancer risk | 12/5/2019

A new study from the National Institutes of Health states that women who use certain beauty products may increase their risk of breast cancer. Permanent dyes and chemical straighteners may increase the risk. Tanya Kovacevic, the manager of FOS Living Organic Hair Salon in Garden City, says most of the salon’s clients are pregnant women or cancer survivors who are looking to be safer when it comes to chemicals. According …

Hair dyes and hair straighteners could pose a risk of breast cancer, especially for black women | 12/5/2019

… a hidden risk. The study found an association between the use of permanent hair dyes and smoothing agents and an increased risk of breast cancer in women, especially in black women. Researchers from the National Institutes of Health studied data from a previous government project to investigate the long-term health of healthy women in the US whose sisters had cancer before, and aptly named this sister study. The project …

Could Hair Dye And Straighteners Increase A Woman’s Risk For Breast Cancer? | 12/5/2019

Could Hair Dye And Straighteners Increase A Woman’s Risk For Breast Cancer? December 4, 2019 at 7:13 pm Filed Under: Breast Cancer , Dr. Max Gomez , Hair Dye NEW YORK (CBSNewYork) – A new study from scientists at the National Institutes of Health suggests hair dye and chemical straighteners could increase a woman’s risk for breast cancer . The news came out of a large national survey called The Sister Study, reports CBS2 …

Could Your Permanent Hair Dye Increase Your Risk Of Developing Breast Cancer? | 12/5/2019

Relying on the creamy crack and covering up those grays with permanent dye may increase your risk of breast cancer, says a recent report published in the International Journal of Cancer . For eight years, the Sister Study, which was conducted by the National Institutes of Health, followed nearly 47,000 cancer-free women between the ages of 35-74 who had sisters that had been diagnosed with the disease in the past …

Permanent hair dye, chemical straighteners tied to breast cancer risk | 12/5/2019

Women who regularly use permanent hair dye and chemical hair straighteners may face a higher breast cancer risk, according to the National Institutes of Health. Data from the more than 46,000 participants in the Sister Study showed the link to be greatest among African American women. Those who used permanent dyes every five to eight weeks or more had a 60% increased risk of breast cancer, compared to an 8 …

Senior-level .Net Developer | 12/5/2019

… Medical Science & Computing (MSC), a Dovel company, is an exciting growth-oriented company, dedicated to providing mission critical scientific and technical services to the Federal Government. We have a distinguished history of supporting the National Institutes of Health (NIH) and other government agencies. MSC offers a dynamic and upbeat work environment, excellent benefits and career growth opportunities. We attract the best people in the business with our competitive benefits package …

Deep Learning Improves Chest X-ray Interpretation | 12/5/2019

… datasets to develop, train and test the models. The first dataset consisted of more than 750,000 images from five hospitals in India, while the second set included 112,120 images made publicly available by the National Institutes of Health (NIH). A panel of radiologists convened to create the reference standards for certain abnormalities visible on chest X-rays used to train the models. “Chest X-ray interpretation is often a qualitative …

STD Awareness: HIV Almost Cured Doesn’t Count – Precinct Reporter Group News | 12/5/2019

Share: By Dianne Anderson What once struck fear in the hearts of everyone can now be managed with a simple pill or two a day. But for all those who lived through the HIV/AIDS terror of the 80s, today’s generation seems to be acting like there’s a cure. However, it may be more a matter of the definition of a cure. Currently, there is a campaign out called U …

Osivax Enters Agreement with U.S. National Institutes of Health to Test Universal Flu Vaccine Candidate | 12/5/2019

Osivax Enters Agreement with U.S. National Institutes of Health to Test Universal Flu Vaccine Candidate Published: Dec 05, 2019 Dec. 5, 2019 10:00 UTC LYON, France–( BUSINESS WIRE )– Osivax announced today that it has entered into an agreement with the United States’ National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) , to further advance the development of its lead universal flu vaccine candidate …

Submission for OMB Review; 30-Day Comment Request; Autism Spectrum Disorder (ASD) Research Portfolio Analysis, NIMH | 12/5/2019

In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. ADDRESSES: Written comments and/or suggestions regarding the …

Submission for OMB Review; 30-Day Comment Request Autism Spectrum Disorder (ASD) Research Portfolio Analysis, NIMH | 12/5/2019

In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. ADDRESSES: Written comments and/or suggestions regarding the …

Auburn research may help develop cure for children with deadly disease | 12/4/2019

… GM1 gangliosidosis. Auburn graduates Sara and Michael Heatherly of Opelika had their son, Porter, taken from them by GM1 in 2016. Porter was the first confirmed case of GM1 in Alabama. According to the National Institutes of Health (NIH) website , “GM1 gangliosidosis is an inherited disorder that progressively destroys nerve cells (neurons) in the brain and spinal cord.” GM1 gangliosidosis is estimated to occur in one in 100,000 to 200,000 …

Worm Guts: A New Weapon Against Drug Resistant Infections | 12/4/2019

Print Gram-negative Klebsiella pneumoniae bacteria Credit: NIAID Health Editor’s Note: Really at this juncture, the issue is not why we have an ever increasing number of drug-resistant germs, but how we can continue to find ways to kill them….Carol Worm Guts May Hold a New Weapon Against Antibiotic-Resistant Germs by National Institutes of Health/Allergy and Infectious Diseases A gruesome fate looms for any caterpillar that …

Study Finds Key Brain Region Smaller in Birth Control Pill Users | PR Newswire | 12/4/2019

CHICAGO , Dec. 4, Researchers studying the brain found that women taking oral contraceptives, commonly known as birth control pills, had significantly smaller hypothalamus volume, compared to women not taking the pill, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA). Located at the base of the brain above the pituitary gland, the hypothalamus produces hormones and helps regulate essential bodily …

Micro-Leads Announces $10M in Funding for Precision Neuromodulation Therapy | BioSpace | 12/4/2019

… launch a clinical study in patients led by Julie Pilitsis, M.D., Ph.D., chair of the Department of Neuroscience and Experimental Therapeutics and professor of Neurosurgery at Albany Medical College. The funding is from the National Institutes of Health initiative Helping to End Addiction Long-Term (HEAL) and private investors and will span multiple years pending completion of milestones.​ Micro-Leads’ high-resolution spinal cord stimulation (SCS) offers a disruptive therapy …

Gene therapy is facing its biggest challenge yet | Nature | 12/4/2019

… not always be worth it. As data drift in from early trials, scientists are working to improve their approaches, and funders have already begun to tackle the equity question. On 23 October, the US National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation announced that they would invest at least $200 million over the next four years to bring gene-based treatments for sickle-cell disease and HIV …

Univ. of Pittsburgh Professor Urges NIH to Continue Rehab Research Efforts - Elite Learning | 12/4/2019

… of Pittsburgh, traveled to Washington, DC on October 30 in conjunction with other advocates from the Disability and Rehabilitation Research Coalition (DRRC) to encourage enhanced rehabilitation research efforts, including occupational therapy studies, at the National Institutes of Health (NIH). The group met with the Deputy Director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the Acting Director of the National Institute of Arthritis and Musculoskeletal and Skin …

NIH

Eolas Therapeutics Announce Initiation of a Phase I Clinical Trial for AZD4041, an Orexin-1 Receptor Antagonist for Smoking Cessation | PRWeb | 12/5/2019

National Institutes of Health (NIH) initiative managed by the National Institute of Neurological Disorders and Stroke (NINDS) that provides non-dilutive support for small molecule drug discovery and development. Healthy volunteers will be treated initially with a single dose of AZD4041. The study endpoints will be safety, tolerability and pharmacokinetics. “There are opportunities for new therapeutics for people with addiction to nicotine and other drugs. The orexin antagonists show promise …

Vedanta Biosciences Awarded $5.8 Million CARB-X Grant to Accelerate Development of VE707 for Multi-Drug Resistant Infections | Business Wire | 12/5/2019

National Institutes of Health (NIH). A non-profit partnership, CARB-X is investing up to $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines, and rapid diagnostics. CARB-X supports the world’s largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X is headquartered at Boston University School of Law. https://carb-x.org/ . Follow us on Twitter @CARB—X. About Vedanta Biosciences Vedanta …

Medical Research

2019: the year gene therapy came of age | Yahoo News | 12/5/2019

… disease, which had caused her painful seizures, came in a year of breakthroughs in one of the hottest areas of medical research – gene therapy. “I have hoped for a cure since I was about 11 … only going to go faster.” Just outside Washington, at the National Institutes of Health (NIH), researchers are also celebrating a “breakthrough period.” “We have hit an inflection point,” said Carrie Wolinetz, NIH’s associate director for …

Food and Drug Administration

Permanent hair dyes, chemical straighteners to linked to increased risk of breast cancer, study find | 12/5/2019

… risk. An 18% higher risk was seen among women who used chemical straighteners. The study, conducted by researchers from the National Institutes of Health and the University of North Carolina-Chapel Hill, was published this … carcinogenic to humans” based on data regarding bladder cancer. The Food and Drug Administration regulates the safety of cosmetics, including hair dyes, but does not approve each ingredient used in the products before they hit …

Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease | BioSpace | 12/5/2019

… for the treatment of NTM pulmonary disease. Spero plans to submit an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) and initiate a Phase 2a clinical trial of SPR720 in … National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, under Award Number R44AI131749. The content is solely the responsibility of the authors and does not necessarily represent the official views …

Clinical Research

Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia | 12/5/2019

… Gastroesophageal reflux was more common among patients who underwent POEM than among those who underwent LHM. (Funded by the European Clinical Research Infrastructure Network and others; ClinicalTrials.gov number, NCT01601678 .) Continue reading this article European Clinical … and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541), and by financial contributions from Harvard University and its affiliated academic health care centers. Disclosure forms provided by …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Myovant Sciences Myrtle Potter & Company Naka International Natera National Institute for Public Health and the Environment National Institute on Aging National Institutes of Health Neoteric Technology NextGen LifeLabs Nobelpharma Norgine Northwestern University Novation Noven Pharmaceuticals … Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women’s Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong Kong University of Michigan University of Oxford University of Siena Upsher-Smith …

CDC

Parkinson’s, Paraquat and Produce | 12/5/2019

… good at causing Parkinson’s that researchers routinely give it to mice to create an animal model. Multiple studies from the National Institutes of Health (NIH) show clear links between the chemical and Parkinson’s. “ It’s about … us are aware of the recent Centers for Disease Control (CDC) report indicating that 1 in every 110 children has some form of autism. Fewer know the work of Dr. Philip Landrigan, of Mt. Sinai …

Heartson’s 9/11 Timeline Part 8 | 12/4/2019

… CDC, Jeffrey Koplan, is resigning effective March 31. And there is currently no director for the National Institutes of Health – NIH is being run by an acting director. The recent resignations leave the three most significant medical positions in the federal government simultaneously vacant. January 21 Gaz de France signs a 20-year deal with BG Group, Edison International, the Egyptian General Petroleum Corporation, and the Egyptian Natural Gas Holding …

Biotech

Vedanta Biosciences Awarded $5.8 Million CARB-X Grant to Accelerate Development of VE707 for Multi-Drug Resistant Infections | Business Wire | 12/5/2019

… Gates Foundation , and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID) , part of the U.S. National Institutes of Health (NIH). A non-profit partnership, CARB-X is investing up to … difficile infection and inflammatory bowel disease (in collaboration with Janssen Biotech, Inc.), and food allergy, as well as a fourth product candidate expected to enter the clinic in 2019 in patients with advanced or metastatic …

2019: the year gene therapy came of age | Yahoo News | 12/5/2019

… all developing very quickly,” said French geneticist Emmanuelle Charpentier, one of Crispr’s inventors and the cofounder of Crispr Therapeutics, the biotech company conducting the clinical trials involving Gray and the German patient. - Cures - Crispr is … only going to go faster.” Just outside Washington, at the National Institutes of Health (NIH), researchers are also celebrating a “breakthrough period.” “We have hit an inflection point,” said Carrie Wolinetz, NIH’s associate director for …

American Heart Association

Whole Fruits can Control Your Blood Pressure | 12/5/2019

… American Heart Association, Chai said. The AHA sets the cap at no more than 6 teaspoons per day for women, no more than 9 teaspoons for men. A much lower cap — 9 teaspoons per week — is set in the DASH (Dietary Approaches to Stop Hypertension) eating plan, developed with funding from the National Institutes of Health. By contrast, Chai said, the average American eats about 17 teaspoons per …

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… the Study of Drug Development Ventana Medical Systems Vertex Pharmaceuticals WaferGen Warnex Worldwide Clinical Trials WuXi AppTec Wuxi Pharmatech Xcovery List of Organizations Mentioned in the Report American College of Cardiology Foundation (ACCF) American Heart Association (AHA) Association for Molecular Pathology (AMP) [US] British Heart Foundation [UK] Broad Institute [US] Cancer Research UK Centers for Medicare and Medicaid Services (CMS) [US] Chinese State Food and Drug Administration (SFDA) Commonwealth Scientific …

Genomics

The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD | 12/5/2019

… 410 triamcinolone and n=408 placebo arm). Of these participants, complete phenotypic information was available in 802 subjects (n=401 triamcinolone and n=401 placebo arm). LHS genotype data are available in the National Institutes of Health database for genotype and phenotype (dbGaP) under study accession phs000335.v3.p2. Genome-wide association testing We performed a genome-wide association study (GWAS) for the FEV 1 change rate (mL·year −1 …

Genome testing for siblings of kids with autism may detect ASD before symptoms appear | 12/5/2019

… clustering of ASD related traits in families,” explains Dr. Stephen Scherer, Senior Scientist and Director of The Centre for Applied Genomics (TCAG) at SickKids, Director of the McLaughlin Centre at the University of Toronto and … Speaks, Autism Speaks Canada, the Simons Foundation Autism Research Initiative, National Institutes of Health (NIH), National Institute of Mental Health (NIMH), Canadian Institutes of Health Research (CIHR), Canada Foundation for Innovation (CFI), Genome Canada, Ontario …

Behavioral Health

Whole Fruits can Control Your Blood Pressure | 12/5/2019

… interest in heart disease, too. And new preliminary data from a study by UD’s Sheau Ching Chai, assistant professor of behavioral health and nutrition, and collaborators show a strong link between added sugar and hypertension … to Stop Hypertension) eating plan, developed with funding from the National Institutes of Health. By contrast, Chai said, the average American eats about 17 teaspoons per day — about 66 pounds per year. Time to …

Could Artificial Intelligence Help Patients With Schizophrenia? | 12/4/2019

… major disturbances. There’s deficiencies in other life functions,” Dr. Joseph Sochet, Outpatient Chief Resident at HealthONE Psychiatry Residency at HealthONE Behavioral Health and Wellness Center told Newsy. “So things like self-care, ability to maintain … becoming less effective. He adds that schizophrenia is rare. The National Institutes of Health say less than one percent of Americans have the mental illness. Related Story …

Substance Abuse

Survey says? Media is kids’ world | 12/5/2019

… the Children and Media Research Advancement Act. If enacted, CAMRA would create a child and media research program within the National Institutes of Health. Researchers would track long-term impacts of social media, apps, mobile … Development study, is already under way. Initially, ABCD focused on substance abuse, but expanded to encompass technology and other factors. Stay tuned. So far, research paints a muddled portrait of kids and tech — some harms …

2019 Executive Director’s annual report | The Bulletin | 12/4/2019

… Surgical Simulation Summit . Key individuals from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Defense (DoD), and National Institutes of Health (NIH) participated and provided information on funding opportunities. The ACS was … covering topics such as chronic disease management, mental health, and substance abuse. Standard setting The four-year Coalition for Quality in Geriatric Surgery (CQGS) Project, funded by The John A. Hartford Foundation, aims to improve …

Merck

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends and developments will prevail? • How will the …

Three HIV Vacs For 2021 *All You Need is One to Work and End Game for The Virus | 12/4/2019

… which are “vaccine components designed to induce immune responses against a wide variety of global HIV strains,” according to the National Institutes of Health . “The presumption is that a mosaic is going to give you … say stop the study,” which happened in 2007 when a Merck vaccine trial was shut down after the monitoring board determined that it had no impact on prevention. “None of these vaccines is a particularly …

Pfizer

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends …

Heartson’s 9/11 Timeline Part 8 | 12/4/2019

… the director of the CDC, Jeffrey Koplan, is resigning effective March 31. And there is currently no director for the National Institutes of Health – NIH is being run by an acting director. The recent resignations … Enron (until recently), Ayala Land, The New York Stock Exchange, Pfizer, and Chevron-Texaco. The exclusive meeting is open to members, who pay upwards of $30,000 in annual dues, as well as selected politicians, journalists …

Novartis

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends and …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

National Institutes of Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics Otsuka Oxford BioMedica Palex Medical Pan American Cancer Treatment Centers PathoQuest Pathway Diagnostics PBM Capital Group Peking University Pfenex Pfizer Pfizer Japan Pharmacosmos PhaseBio Pharmaceuticals Pieris Portola Pharmaceuticals Premier Inc Promethera Biosciences Prophylix Pharma Protagonist Therapeutics Provepharm Qiagen Quotient Bioscience Regen BioPharma Research Center for …

Thermo Fisher

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Critical Diagnostics • Epigenomics • Genomic Health • ICON plc • Laboratory Corporation of America Holdings • MDxHealth (formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Myovant Sciences Myrtle Potter & Company Naka International Natera National Institute for Public Health and the Environment National Institute on Aging National Institutes of Health Neoteric Technology NextGen LifeLabs Nobelpharma Norgine Northwestern University Novation Noven Pharmaceuticals … Tessa Therapeutics Teva Pharmaceutical Industries Teva Pharmaceuticals USA Theramex TherapeuticsMD Thermo Fisher Scientific Transgene Trimel Pharmaceuticals Trivector Biomed Trophogen twoXAR Unified Women’s Clinical Research University College Dublin Conway Institute University Magna Graecia University of Hong …

GlaxoSmithKline

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Institute for Innovation Foresee Pharmaceuticals Fougera Pharmaceuticals Fuji Pharma Genea Biomedx Genoma Genome Medical German Cancer Research Center Gilead Sciences GlaxoSmithKline GOG Foundation Golden Valley Development Good Start Genetics Grunenthal Guided Therapeutics Gynica Halt Medical … for Public Health and the Environment National Institute on Aging National Institutes of Health Neoteric Technology NextGen LifeLabs Nobelpharma Norgine Northwestern University Novation Noven Pharmaceuticals Novogene NX Prenatal OBP Medical ObsEva Olympus OncoSec Medical Oncotest …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Benzinga | 12/4/2019

… Institute for Innovation Foresee Pharmaceuticals Fougera Pharmaceuticals Fuji Pharma Genea Biomedx Genoma Genome Medical German Cancer Research Center Gilead Sciences GlaxoSmithKline GOG Foundation Golden Valley Development Good Start Genetics Grunenthal Guided Therapeutics Gynica Halt Medical … for Public Health and the Environment National Institute on Aging National Institutes of Health Neoteric Technology NextGen LifeLabs Nobelpharma Norgine Northwestern University Novation Noven Pharmaceuticals Novogene NX Prenatal OBP Medical ObsEva Olympus OncoSec Medical Oncotest …

GSK

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs: • Pfizer • Novartis • Roche Diagnostics • Ventana Medical Systems • Merck & Co. • Sanofi • GSK • Abbott Laboratories • AstraZeneca • Key questions answered by this report: • How is the biomarkers market evolving? • What is driving and restraining the biomarker market dynamics? • Which trends and developments will prevail? • How will the market shares of …

Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease | 12/3/2019

… National Institutes of Health, the U.S. Food and Drug Administration, with industry (Celgene, GSK, Pfizer, Sanofi and Verily) and non-profit (The Michael J. Fox Foundation for Parkinson’s Research) organizations and managed through the Foundation for the National Institutes of Health (FNIH). The goal of this partnership is to transform and accelerate drug development in PD by providing the expertise and support needed to determine which biomarkers show the greatest …

Celgene

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Beijing Genomics Institute) Biofortis Biosoft BRAHMS (part of Thermo Fisher Scientific) Brigham and Women’s Hospital Bristol- Myers Squibb Cancer Research Technology Caprion Proteomics CBC (Comprehensive Biomarker Centre GmbH) Celera (part of Quest Diagnostics) Celgene Cell Signaling Technology Celldex Therapeutics Cephalon (part of Teva) Charles River Laboratories Chronix Biomedical Chugai Pharmaceutical Ciphergen Biosystems Clarient Diagnostic Services Cleveland HeartLab Clinigene International Comprehensive Biomarker Center (formerly Febit) Covance Crelux Critical Diagnostics Critical Path …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences CEI Celgene Central California Blood Center Cerus Cesca Therapeutics Children’s Hospital of Philadelphia Children’s Minnesota China … Foundation National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics …

Gilead Sciences

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Health Fogarty Institute for Innovation Foresee Pharmaceuticals Fougera Pharmaceuticals Fuji Pharma Genea Biomedx Genoma Genome Medical German Cancer Research Center Gilead Sciences GlaxoSmithKline GOG Foundation Golden Valley Development Good Start Genetics Grunenthal Guided Therapeutics Gynica … for Public Health and the Environment National Institute on Aging National Institutes of Health Neoteric Technology NextGen LifeLabs Nobelpharma Norgine Northwestern University Novation Noven Pharmaceuticals Novogene NX Prenatal OBP Medical ObsEva Olympus OncoSec Medical Oncotest …

Investigational Drugs Reduce Risk of Death from Ebola Virus Disease | 12/4/2019

… Research (INRB) and Ministry of Health, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health. Professor Jean-Jacques Muyembe-Tamfum, M.D., Ph.D., director-general of the … Regeneron Pharmaceuticals, Inc.; and remdesivir, an antiviral drug developed by Gilead Sciences, Inc. The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, also has provided support …

Qiagen

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Axela Inc • Caprion Proteomics • Charles River Laboratories • Critical Diagnostics • Epigenomics • Genomic Health • ICON plc • Laboratory Corporation of America Holdings • MDxHealth (formerly OncoMethylome) • Myriad Genetics • Oxford Gene Technology (OGT) • Pacific Biomarkers • Parexel • Proteome Sciences • QIAGEN • Quest Diagnostics • Quintiles IMS Holdings Inc • Thermo Fisher Scientific • Worldwide Clinical Trials (WWC) • WuXi PharmaTec • Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

National Institutes of Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics Otsuka Oxford BioMedica Palex Medical Pan American Cancer Treatment Centers PathoQuest Pathway Diagnostics PBM Capital Group Peking University Pfenex Pfizer Pfizer Japan Pharmacosmos PhaseBio Pharmaceuticals Pieris Portola Pharmaceuticals Premier Inc Promethera Biosciences Prophylix Pharma Protagonist Therapeutics Provepharm Qiagen Quotient Bioscience Regen BioPharma Research Center for …

Biogen

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Baylor College of Medicine Beijing Leadman Biochemistry Belgian Red Cross Bicycle Therapeutics Bill and Melinda Gates Foundation Biocept BIOCORP bioCSL Biogen BioMatrix Specialty Pharmacy Biomedical Advanced Research and Development Authority BioMedical Drug Development BioNano Genomics … Foundation National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Baylor College of Medicine Beijing Leadman Biochemistry Belgian Red Cross Bicycle Therapeutics Bill and Melinda Gates Foundation Biocept BIOCORP bioCSL Biogen BioMatrix Specialty Pharmacy Biomedical Advanced Research and Development Authority BioMedical Drug Development BioNano Genomics … Foundation National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics …

Lincoln Park Capital Fund

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

Lincoln Park Capital Fund Lonza The University of Texas MD Anderson Cancer Center Mallinckrodt Pharmaceuticals Marina Biotech Massachusetts Institute of Technology Medison Pharma miRagen Therapeutics miReven MirImmune Mirimus Moderna Therapeutics Moore Venture Partners MP Healthcare Venture Management MRL Ventures Fund (MRLV) Nant Capital NantVentures National Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC …

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | Markets Insider | Business Insider | 11/27/2019

Lincoln Park Capital Fund Lonza The University of Texas MD Anderson Cancer Center Mallinckrodt Pharmaceuticals Marina Biotech Massachusetts Institute of Technology Medison Pharma miRagen Therapeutics miReven MirImmune Mirimus Moderna Therapeutics Moore Venture Partners MP Healthcare Venture Management MRL Ventures Fund (MRLV) Nant Capital NantVentures National Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC …

Goldman Sachs

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… F-Prime Capital GeneCopoeia GeneCust GeneDesign GENEL Genentech GenePharma Genesis Pharmaceuticals Sanofi Genzyme / Genzyme Genomics England GlaxoSmithKline (GSK) Glycostem Therapeutics Goldman Sachs Gradalis Gritstone Oncology Guang’anmen Hospital of China Academy of Chinese Medical Sciences Harvard … Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore …

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | Markets Insider | Business Insider | 11/27/2019

… F-Prime Capital GeneCopoeia GeneCust GeneDesign GENEL Genentech GenePharma Genesis Pharmaceuticals Sanofi Genzyme / Genzyme Genomics England GlaxoSmithKline (GSK) Glycostem Therapeutics Goldman Sachs Gradalis Gritstone Oncology Guang’anmen Hospital of China Academy of Chinese Medical Sciences Harvard … Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore …

Bain Capital

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… Institute of Molecular and Cell Biology (IMCB), A STAR Atlas Venture AUM LifeTech Avecia Biotechnology Avidity Biosciences Axovant Gene Therapies Bain Capital Life Sciences Benitec Biopharma Biogen Biomics Biotechnologies (a GE Unit) Bioneer BioNTech Biosettia … Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore …

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | Markets Insider | Business Insider | 11/27/2019

… Institute of Molecular and Cell Biology (IMCB), A STAR Atlas Venture AUM LifeTech Avecia Biotechnology Avidity Biosciences Axovant Gene Therapies Bain Capital Life Sciences Benitec Biopharma Biogen Biomics Biotechnologies (a GE Unit) Bioneer BioNTech Biosettia … Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore …

Morgan Stanley

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 2 of 4 - Saama Technologies | 11/13/2019

… FDA and PMDA. Dr. Kush has over 30 years of experience in clinical research, including positions with academia, the U.S. National Institutes of Health, a global CRO and biopharmaceutical companies in the U.S. and Japan … Before working for Goldman Sachs, he was an associate at Morgan Stanley, where he worked in the Telecom/Media Mergers & Acquisitions Group. Marc earned his MBA with a concentration in finance and accounting from The …

Anna Penn, MD, PhD, to Lead Neonatology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children’s Hospital | PR Newswire | 11/12/2019

Anna Penn, MD, PhD, to Lead Neonatology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children’s Hospital News provided by Columbia University Irving Medical Center Nov 12, 2019, 11:47 ET NEW YORK … than $20 million per year in research funding from the National Institutes of Health , and it is the only department of pediatrics in New York ranked among the top 25 in the United States by …

Leerink Transformation Partners

Scientist.com Recognized as One of North America’s Fastest-Growing Companies by Deloitte | Business & Finance | manchestertimes.com | Business Wire | 11/12/2019

National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit scientist.com to learn more. View source version on businesswire.com : https://www.businesswire.com/news/home/20191112005392/en/ CONTACT: Sean Preci +1 858 455-1300 ext. 401 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: RESEARCH TECHNOLOGY OTHER TECHNOLOGY NETWORKS BIOTECHNOLOGY INTERNET GENERAL HEALTH PHARMACEUTICAL HEALTH …

5AM Ventures

Scientist.com Recognized as One of North America’s Fastest-Growing Companies by Deloitte | Business & Finance | manchestertimes.com | Business Wire | 11/12/2019

National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit scientist.com to learn more. View source version on businesswire.com : https://www.businesswire.com/news/home/20191112005392/en/ CONTACT: Sean Preci +1 858 455-1300 ext. 401 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: RESEARCH TECHNOLOGY OTHER TECHNOLOGY NETWORKS BIOTECHNOLOGY INTERNET GENERAL HEALTH PHARMACEUTICAL HEALTH …

New Enterprise Associates

It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill | STAT | 11/12/2019

… companies, according to data from BIO. The modern drug development process goes like this: A discovery is made at the National Institutes of Health or in an academic lab, small biotech entrepreneurs spin the idea … Dr. Sara Nayeem, a partner at the venture capital firm New Enterprise Associates. “It’s a bit frightening actually to see the specter of just a complete blunt instrument dampening innovation that may have a short …

Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by NEA and Announces the Formation of a World-Class Scientific Advisory Board, to Advance a First-in-Class RNA Editing Gene Therapy Platform Focused on Curing Genetic Diseases | Business Wire | 11/5/2019

… development-stage biotechnology company leading the field of RNA-editing gene therapy, announces $35.5M in Series A financing, led by New Enterprise Associates (NEA), with additional participation from CureDuchenne Ventures. The new capital will enable … U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science. He has received numerous awards, including the 2011 Bower Award and Prize for Achievement in …

Bridge Bank

CytoSorbents Reports Third Quarter 2019 Financial | 11/6/2019

… expectation to file HemoDefend IDE to FDA before year end Strengthened cash position with addition of $5M of debt from Bridge Bank with interest-only period extended to November 2020 , provided certain conditions are met … Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM), the U.S. Army, U.S. Special Operations Command (USSOCOM …

CytoSorbents Reports Third Quarter 2019 Financial Results | PR Newswire | 11/5/2019

… expectation to file HemoDefend IDE to FDA before year end Strengthened cash position with addition of $5M of debt from Bridge Bank with interest-only period extended to November 2020 , provided certain conditions are met … Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM), the U.S. Army, U.S. Special Operations Command (USSOCOM …

Khosla Ventures

TIME Convenes the First-Ever TIME 100 Health Summit in New York, NY | PR Newswire | 10/17/2019

… Secretary of the U.S. Department of Health and Human Services Alex Azar , former Vice President Al Gore , director of the National Institutes of Health Dr. Francis Collins , physician Dr. Leana Wen , advocate Selma Blair , CEO … Association as Knowledge Partner, The Rockefeller Foundation as Supporting Partner, Khosla Ventures as Promotional Partner, and Smartsheet as Technology Partner. For more information about the TIME 100 Health Summit, visit: https://time.com/health-summit/ CONTACT …

Neurotrack raises $21 million to detect and track dementia | VentureBeat | 6/11/2019

Khosla Ventures, with participation from strategic investors Sozo Ventures, Japanese insurance providers Dai-ichi Life and Sompo Holdings, Rethink Impact, and AME Cloud Partners. Previous backers include Johnson & Johnson and the Georgia Research Alliance (GRA) The fresh capital brings Neurotrack’s total funding to date to $50 million, which includes over $7 million in grants from the National Institutes of Health. The company says the investments will be used to drive …

Illumina Ventures

Novel Cell Sorting and Separation Markets, 2030 | PR Newswire | 10/7/2019

… Humacyte Humanitas Research Hospital Hunan Agen Medicine Laboratory Technology IBA Lifesciences Icahn School of Medicine ICE Angels iCellate ICREA Ignyta Illumina Ventures IMEC immatics biotechnologies Immunomedics ImmunoQure Inabata Inbiomotion IncellDx IncoCell Tianjin Incyte Inguran Innate … Institute of Drug Abuse National Institute of General Medical Sciences National Institutes of Health National University Hospital National University of Ireland Galway’s Regenerative Medicine Institute National University of Singapore Naval Research Laboratory Nektar Therapeutics NeoDiagnostix …

Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform | Business & Finance | heraldchronicle.com | Business Wire | 9/27/2019

… RNA to treat human diseases, today announced $7.8 million in additional funding from existing investors, the Dementia Discovery Fund and Illumina Ventures. Ribometrix also announced the appointment of Mike Clayman, M.D., as chairman of the … is the recipient of the Physician Scientist Award from the National Institutes of Health. He holds a B.A. from Yale University and an M.D. from the University of California, San Diego School of Medicine. “Ribometrix …

Harvard Medical School

Reprogramming the Inner Ear to Regrow Hair Cells Shows Promise to be an Effective Target for Hearing Loss Treatments | 12/4/2019

… the Eaton-Peabody Laboratories at Mass. Eye and Ear, and an Associate Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School. “These findings of renewed proliferation and hair cell generation in a fully … he added. Dr. Chen’s new study was funded by the National Institutes of Health (NIH R01DC006908), Department of Defense (DOD W81XWH1810331, Fredrick and Ines Yeatts hair cell regeneration fellowship and David-Shulsky Foundation (Z768). Patent …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Foundation National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics …

Mayo Clinic

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Insight Genetics Institute of Pathology Heidelberg (IPH) Integrated Diagnostics Ipsen Ipsogen (a subsidiary of QIAGEN) Isogen Life Science Johnson & Johnson (J&J) KU Leuven (University of Leuven) LabCorp Life Technologies LightArray Biotech M2Gen Mayo Clinic [US] Mayo Collaborative Services MDxHealth Medical Research Council [UK] MediMedia Pharma Solutions Memorial Sloan-Kettering Cancer Center [US] Merck & Co. Merck KGaA Metabolon Michael J Fox Foundation Myriad Genetics Myriad RBM (formerly Rules-Based Medicine …

Cognizance Biomarkers Initiates Clinical Trial to Confirm Its Test Can Distinguish Epileptic Seizures from Psychogenic Nonepileptic Seizures | PR Newswire | 12/4/2019

Mayo Clinic that aims to confirm its blood-based protein biomarker test and algorithm accurately distinguish epileptic seizures (ES) from psychogenic nonepileptic seizures (PNES). The trial is supported by a recently awarded grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R43NS113724. The new clinical trial is intended to confirm the results of a clinical study reported at the 2018 …

Cleveland Clinic

Cleveland Clinic awarded $2.8 million to study ecological, evolutionary contributors to cancer | 12/4/2019

Cleveland Clinic awarded $2.8 million to study ecological, evolutionary contributors to cancer Understanding interaction of these influences may lead to new treatment options Cleveland Clinic Print E-Mail Jacob Scott, M.D., Ph.D., a physician researcher from Cleveland Clinic’s Department of Translational Hematology and Oncology Research, recently received a $2.8 million grant from the National Cancer Institute, part of the National Institutes of Health, to study how ecological and evolutionary mechanisms …

Cleveland Clinic to study ecological, evolutionary mechanisms that contribute to lung cancer | 12/4/2019

Jacob Scott, M.D., Ph.D., a physician researcher from Cleveland Clinic’s Department of Translational Hematology and Oncology Research, recently received a $2.8 million grant from the National Cancer Institute, part of the National Institutes of Health, to study how ecological and evolutionary mechanisms contribute to lung cancer development and progression, and how the interplay between these mechanisms may provide novel treatment insights. With this new grant, Dr. Scott will build on …

Cleveland Clinic, Cleveland OH

Cleveland Clinic awarded $2.8 million to study ecological, evolutionary contributors to cancer | 12/4/2019

Cleveland Clinic awarded $2.8 million to study ecological, evolutionary contributors to cancer Understanding interaction of these influences may lead to new treatment options Cleveland Clinic Print E-Mail Jacob Scott, M.D., Ph.D., a physician researcher from Cleveland Clinic’s Department of Translational Hematology and Oncology Research, recently received a $2.8 million grant from the National Cancer Institute, part of the National Institutes of Health, to study how ecological and evolutionary mechanisms …

Cleveland Clinic to study ecological, evolutionary mechanisms that contribute to lung cancer | 12/4/2019

Jacob Scott, M.D., Ph.D., a physician researcher from Cleveland Clinic’s Department of Translational Hematology and Oncology Research, recently received a $2.8 million grant from the National Cancer Institute, part of the National Institutes of Health, to study how ecological and evolutionary mechanisms contribute to lung cancer development and progression, and how the interplay between these mechanisms may provide novel treatment insights. With this new grant, Dr. Scott will build on …

UPMC

(USA-PA-Altoona) Registered Nurse - Surgical Trauma Stepdown | 12/4/2019

UPMC Registered Nurse - Surgical Trauma Stepdown in Altoona , Pennsylvania Description This position is eligible for a generous sign-on bonus! Whether you’re a recent Graduate Nurse looking to launch your nursing career, or a seasoned RN seeking a change, now is your moment to find your place at UPMC! Sign-On Bonus Details (Full Time or Flex Full Time status) • $10,000 sign-on bonus available for nurses with over two …

Precision medicine, population health offer two sides to health improvement | Modern Healthcare | 11/30/2019

… Us Research Program, a project Obama hinted at in his 2015 speech. All of Us, which is housed in the National Institutes of Health, launched in May of last year . It fulfills a mandate of … Medicine, a center jointly operated by GE Healthcare, Nokia and UPMC. However, based on health systems’ responses, KLAS Research and the Center for Connected Medicine categorized just 12% of their precision medicine programs as mature …

Ascension

100 hospitals and health systems with great orthopedic programs | 2019 | Becker’s Hospital Review | 12/4/2019

… other local teams. It supports joint replacement and preservation, spine and sports medicine as well as orthopedic concierge services. The National Institutes of Health has granted the orthopedic surgery departments research funding for its projects … Wisconsin (Glendale). Orthopaedic Hospital of Wisconsin is a member of Ascension Wisconsin and serves patients from across the state. Since being established in 2001 as a joint venture between a group of orthopedic surgeons and …

First Edition: November 25, 2019 | Kaiser Health News | 11/25/2019

… a probe into a partnership that allowed Google (GOOGL) to collect millions of patient records from the nonprofit hospital chain Ascension. At the crux of the investigation: whether the companies adhered to HIPAA, or the … for Complementary and Integrative Health can help. Part of the National Institutes of Health, the agency is devoted to determining what complementary and alternative medical approaches are useful and safe — and which ones aren’t. (Blakemore …

UCLA Health

UCLA launches new master’s degree in genetic counseling in fall 2020 | 12/4/2019

… National Institutes of Health, UCLA is uniquely positioned to train the future generation of genetic counselors. “UCLA Health is an integrated health system where we have made precision health a priority,” said Clara Lajonchere, deputy director of the UCLA Institute for Precision Health at the Geffen School of Medicine. “Genetic counselors are an important part of the precision health ecosystem and play a vital role in the delivery of patient …

Vegan diet can accommodate need for choline | 11/29/2019

… choline is so important to development, women who are pregnant or nursing need more of the nutrient. According to the National Institutes of Health, most people in the United States, whether vegans, vegetarians or omnivores … MBA, is an internist and associate professor of medicine at UCLA Health. Elizabeth Ko, M.D., is an internist and assistant professor of medicine at UCLA Health. Send your questions to , or write: Ask the Doctors …

Montefiore Medical Center

Study Finds Key Brain Region Smaller in Birth Control Pill Users | PR Newswire | 12/4/2019

… at the Gruss Magnetic Resonance Research Center at Albert Einstein College of Medicine and medical director of MRI Services at Montefiore Medical Center in New York City . “We validated methods for assessing the volume of … and Chloe Ifrah , B.A. The study was funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke and by The Dana Foundation. Note: Copies of RSNA 2019 news releases and electronic …

NYU Langone Health

Concussion Alters How Information Is Transmitted Within the Brain | PR Newswire | 12/3/2019

… to better understand the white matter microstructural injury that occurs,” said study co-author Melanie Wegener , M.D., resident physician at NYU Langone Health in New York City . Dr. Wegener and colleagues combined the MRI findings … Yvonne W. Lui , M.D. The study was funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke. Note: Copies of RSNA 2019 news releases and electronic images will be available online …

Concussion Alters How Information Is Transmitted Within the Brain | BioSpace | 12/3/2019

… to better understand the white matter microstructural injury that occurs,” said study co-author Melanie Wegener , M.D., resident physician at NYU Langone Health in New York City . Dr. Wegener and colleagues combined the MRI findings … Yvonne W. Lui , M.D. The study was funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke. Note: Copies of RSNA 2019 news releases and electronic images will be available online …

Johns Hopkins University School of Medicine

Psychedelic Science: A Conversation with Roland Griffiths | 12/3/2019

… Johns Hopkins University School of Medicine, and founding Director of the Johns Hopkins Center on Psychedelic and Consciousness Research. He is author of over 380 journal articles and book chapters, and has trained more than 50 postdoctoral research fellows. Roland has been a consultant to the National Institutes of Health, to numerous pharmaceutical companies in the development of new psychotropic drugs, and as a member of the Expert Advisory Panel …

Mushrooms, meetups and mainstreaming the movement to decriminalize drugs | Crosscut | 11/25/2019

National Institutes of Health gave cautious encouragement to using psychedelics in research, even though they fall under the most severe federal prohibition. Then, in September, Johns Hopkins University School of Medicine announced the creation of a new center dedicated to researching psychedelics. Meanwhile, in an elegant bungalow in northeast Seattle, a small circle of activists and “psychonauts” — among them a medical doctor, Youngs and another recovery coach and a veteran …

Aetna

Calculating the Costs of Clinical Trials | 12/1/2019

… the hidden costs of trial participation Of the three potential risks of participating in a clinical trial listed on the National Institutes of Health (NIH) website, two are related to the potential costs, hidden and … and established standards of care for a particular diagnosis.” 5 Aetna’s website stipulates that “all applicable plan limitations for coverage of out-of-network care will apply to routine care costs in clinical trials.” 6 …

Cigna

Calculating the Costs of Clinical Trials | 12/1/2019

… the hidden costs of trial participation Of the three potential risks of participating in a clinical trial listed on the National Institutes of Health (NIH) website, two are related to the potential costs, hidden and … will apply to routine care costs in clinical trials.” 6 Cigna’s clinical trial fact sheet notes that routine patient services, such as transplant-related services or select outpatient services, are managed the same way whether …

Harvard Pilgrim Health Care

Harvard Wyss Institute researchers demonstrate machine-guided engineering of AAV capsids | 11/30/2019

… of Engineering and Applied Sciences (SEAS). The study was funded by Harvard’s Wyss Institute for Biologically Inspired Engineering and the National Institutes of Health. PRESS CONTACT Wyss Institute for Biologically Inspired Engineering at Harvard University … and Women’s Hospital, Cambridge Health Alliance, Dana-Farber Cancer Institute, Harvard Pilgrim Health Care Institute, Hebrew SeniorLife, Joslin Diabetes Center, Judge Baker Children’s Center, Massachusetts Eye and Ear/Schepens Eye Research Institute, Massachusetts General Hospital …

Witnessing The Vaccine Injury Epidemic: We will NOT be Silent! We will NOT Give Up! | 11/29/2019

… Aug. 5, 2019. 69 MedAlerts. Vaccine adverse event reports made to the Vaccine Adverse Event Reporting System (VAERS) 2015-2019 . 70 Harvard Pilgrim Health Care, Inc. Electronic System for Public Health Vaccine Adverse Event Reporting System … from 2001 to 2009 . JAMA 2014; 311(17): 1778-1786. 104 National Institutes of Health. Rates of diagnosed cases of type 1 and type 2 diabetes on the rise among children, teens . Apr. 13, 2017. 105 …

Health Net

Year in Review: Rheumatic Disease Research in 2019 | 11/21/2019

… This Author Susan Manzi, MD, MPH, director of the Lupus Center for Excellence in the Autoimmunity Institute at the Allegheny Health Network in Pittsburgh, who reviewed the clinical headlines, called it “the year for psoriatic … he said. The Accelerating Medicines Partnership—a collaboration by the National Institutes of Health, the Food and Drug Administration, companies and nonprofit organizations—is transforming the approach to drug development, with $42.2 million dedicated to …

Allegheny Health Networks Dr. Susan Manzi receives prestigious award for outstanding contributions to the field of rheumatology | 11/21/2019

Posted November 20th, 2019 for Allegheny Health Network Wednesday, November 20, 2019 PITTSBURGH – Allegheny Health Network’s Susan Manzi, MD, MPH , is the recipient of the American College of Rheumatology’s 2019 Distinguished Clinical Investigator Award. She … program has been generously supported by organizations such as the National Institutes of Health (NIH), Department of Defense, Lupus Foundation of America and the Arthritis Foundation. Dr. Manzi has served on advisory boards for the …

Humana

Serum-Free Culture of Human Mesenchymal Stem Cell Aggregates in Suspension Bioreactors for Tissue Engineering Applications | 11/7/2019

… microscope equipped with 5x (NA 0.15), 10x (NA 0.30), and 20x (NA 0.30) objectives. IHC staining was quantified using ImageJ (National Institutes of Health, USA) and an IHC profiler open source plugin that quantifies the … Ceuninck, M. Sabatini, and P. Pastoureau, Eds., pp. 127–156, Humana Press, 2004. View at Publisher · View at Google Scholar Z. Li, L. Kupcsik, S.-J. Yao, M. Alini, and M. J. Stoddart, “Chondrogenesis of …

In Situ Endoscopic Analysis of Vascular Supply and Regenerated Alveolar Bone in β-TCP Grafted and Ungrafted Postextraction Sites before Implant Placement: A Prospective Case Control Study | 11/6/2019

… the original digital video archives (mpg4 files) and stored in jpg format. The image analysis program (Image J, V.64, National Institutes of Health, Bethesda, MD, USA) was used to open digitized endoscopic images. 1.4 … in Methods in Molecular Biology , vol. 931, pp. 123–137, Humana Press, Totowa, NJ, USA, 2013. View at Publisher · View at Google Scholar W. Engelke, M. Lazzarini, W. Stühmer, and V. Beltrán, “Support immersion endoscopy …

Indian Health Service

Amanda Darman-Allen Joins SmartBrief as Chief Partnership Officer | 10/29/2019

Indian Health Service and the National Institutes of Health. She later moved into the nonprofit sector, driving corporate partnerships and fundraising efforts for organizations such as the Make-A-Wish Foundation of America and the Cystic Fibrosis Foundation. A native of the Washington, D.C., area, Darman-Allen graduated from the University of Maryland with a B.A. in communications and public relations. She will report directly to CEO Rick Stamberger. About …

Tuesday, October 8, 2019 | Kaiser Health News | 10/8/2019

… shared during a congressional field hearing in Albuquerque. Dr. Loretta Christensen — the chief medical officer on the Navajo Nation for Indian Health Service, a partner in the research — said 781 women were screened during an … to definitively link vaping nicotine to cancer. Funded by the National Institutes of Health, the study was published Monday in the Proceedings of the National Academy of Sciences. (Bursztynsky, 10/7) Meanwhile, in the states — The …

Donald Trump

An Effort to Improve Scientific Integrity in Government | 12/5/2019

… down on Florida, Georgia, and the Carolinas. But while many of these states anticipated evacuation warnings and property damage, President Donald Trump falsely claimed the storm could also endanger Alabama. Leaders of the National Oceanic … organization. A few agencies, the report argues, such as the National Institutes of Health, have nonexistent or poor policies; others, like NASA and the National Science Foundation, have policies but lack the staff to make …

News 12 Now PM - Some charges may be dropped by judge in case against driver in Boy Scout death | 12/5/2019

… Donald Trump. Study: Hair dyes, chemical straighteners may increase breast cancer risk A new study from the National Institutes of Health states that women who use certain beauty products may increase their risk of breast cancer. Levittown family reaches out for support as 7-month-old battles rare genetic disease A Levittown family is reaching out to the public for support for their 7-month-old daughter, as she battles …

Francis Collins

Gene therapy is facing its biggest challenge yet | Nature | 12/4/2019

… working to improve their approaches, and funders have already begun to tackle the equity question. On 23 October, the US National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation announced that they would … To do otherwise “would be almost unethical”, says NIH director Francis Collins. Collins thinks that the key to fulfilling the NIH’s project with the Gates foundation will be in finding ways to deliver the corrected …

The Alliance of Genome Resources: Building a Modern Data Ecosystem for Model Organism Databases [Commentary] | 12/3/2019

… GOC) in the peer-reviewed scientific literature demonstrate that these resources are widely used to support science funded across all National Institutes of Health (NIH) Institutes and have global impact. These resources also have been … Academy of Sciences. It was presented to the NIH Director, Francis Collins, at The Allied Genetics Conference (TAGC) in the summer of 2016 (Organizers of The Allied Genetics Conference 2016). As a follow-up to …

Melinda Gates

Gene therapy is facing its biggest challenge yet | Nature | 12/4/2019

National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation announced that they would invest at least $200 million over the next four years to bring gene-based treatments for sickle-cell disease and HIV to low-resource settings. Bakatunkanda, who founded a support group for people with sickle-cell disease, is confident that gene therapy, if shown to be effective, will one day reach his country, despite its …

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Scientific Bavarian Nordic Bayer Bayer Healthcare Baylor College of Medicine Beckman Coulter Beijing Genomics Institute (BGI) Besins Healthcare Bill and Melinda Gates Foundation Biocon Biomnis Biotech Inc BL&H Bluebird Bio BMV Medica Boston Scientific … for Public Health and the Environment National Institute on Aging National Institutes of Health Neoteric Technology NextGen LifeLabs Nobelpharma Norgine Northwestern University Novation Noven Pharmaceuticals Novogene NX Prenatal OBP Medical ObsEva Olympus OncoSec Medical Oncotest …

Bernie Sanders

Rep. Ro Khanna Says FOSTA/SESTA ‘Criminalized Online Sex Work’ | 12/4/2019

… representative from Fremont, California, represents much of Silicon Valley. Despite representing many of the big tech companies that Democratic candidate Bernie Sanders has pledged to “break up,” Khanna serves as co-chair of Sanders’ 2020 … added . Khanna said that his bill will call for the National Institutes of Health to study the effects of FOSTA/SESTA. But Khanna still did not give a date for when he plans to introduce …

DeVos promises ‘groundbreaking speech’ on Federal Student Aid - POLITICO | 12/3/2019

… Vt.) and Reps. Nita Lowey (D-N.Y.) and Kay Granger (R-Texas). — At issue, Woolley wrote, is funding for the National Institutes of Health, the CDC, the Agency for Healthcare Research and Quality, the FDA … and rally starting at 10:30 a.m., organizers said Monday. Sen. Bernie Sanders (I-Vt.) a Democratic presidential contender, pledged his support on Twitter . UNIVERSITY OF CHICAGO STUDENTS WANT CHARGES DROPPED AGAINST FORMER STUDENT SHOT BY …

Anthony Fauci

Three HIV Vacs For 2021 *All You Need is One to Work and End Game for The Virus | 12/4/2019

… vaccine would be “a tremendous breakthrough,” and “would really have the power to change the trajectory of the epidemic.” Dr. Anthony Fauci, director of NIAID and a longtime advocate for a vaccine that is at … a wide variety of global HIV strains,” according to the National Institutes of Health . “The presumption is that a mosaic is going to give you broader coverage,” Fauci said. In November, the third vaccine trial …

Building a better flu vaccine – one you don’t have to get every year | 12/4/2019

… year, the effectiveness of the vaccine is about 60%. On a bad year, it’s as low as 10%,” said Dr. Anthony Fauci , director of the National Institute of Allergy and Infectious Diseases (NIAID). “And there’s … Research Center at NIAID, which is a part of the National Institutes of Health, and one of several sites around the US participating in the vaccine trial. With the seasonal vaccines we receive now, each …

David Geffen

UCLA launches new master’s degree in genetic counseling in fall 2020 | 12/4/2019

… Schmidt December 3, 2019 To meet the rising demand for specialists trained to guide patients facing complex genetic disorders, the David Geffen School of Medicine at UCLA is introducing a new master’s of science degree … clinical site of the Undiagnosed Disease Networks funded by the National Institutes of Health, UCLA is uniquely positioned to train the future generation of genetic counselors. “UCLA Health is an integrated health system where we …

New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes | Yahoo News | 12/2/2019

… extend beyond abstinence and treatment retention,” said the study’s lead author, Walter Ling , MD, Research Professor, Department of Family Medicine, David Geffen School of Medicine, UCLA . “These results showed that patients experienced improvements in physical … Health and Human Services (HHS), National Institute on Drug Abuse, National Institutes of Health. Drugs, Brains, and Behavior: The Science of Addiction. HHS Publication No. (SMA) 18-5063PT5, Printed 2018. 6. Ling W, Nadipelli VR, Solem …

Kamala Harris

Auburn research may help develop cure for children with deadly disease | 12/4/2019

… taken from them by GM1 in 2016. Porter was the first confirmed case of GM1 in Alabama. According to the National Institutes of Health (NIH) website , “GM1 gangliosidosis is an inherited disorder that progressively destroys … it to the playoff. 5. Harris is out U.S. Senator Kamala Harris (D-CA) has written a note to her supporters to let them know that she is ending her 2020 Democratic presidential campaign, saying …

Daaybreak: California touts climate friendly farmers | 12/3/2019

… Listen Newsom campaigning in Iowa Gov. Gavin Newsom is heading to Iowa later this month to campaign for California Sen. Kamala Harris. Newsom has ruled out running for president himself this round, but the trip … not contain those specific priorities. NIMH, a unit of the National Institutes of Health, has asked for comments on the proposal , which is published in today’s Federal Register. On that note: CDFA Secretary Karen Ross …

Ned Sharpless

Marijuana criminalization could be clouding info on vaping deaths | 12/4/2019

… Center for Tobacco Regulatory Science and Lung Health. The roughly one dozen researchers in the Oct. 23 meeting told the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and … in a statement. But there are challenges, FDA acting Commissioner Ned Sharpless testified to Congress in September, including low levels of leftover juice and problems in determining which of the products a patient vaped caused …

12 burning questions for Stephen Hahn, Trump’s pick to lead FDA | STAT | 11/20/2019

… bumped to 2022, until a federal court ordered it moved up to May 2020. Earlier this year, acting FDA Commissioner Ned Sharpless said in a congressional hearing that the agency “should have acted sooner” to … research being conducted by scientists at the FDA and the National Institutes of Health. HHS also said that any grant application for new or renewed funding for fetal tissue research conducted by outside scientists would …

Pete Buttigieg

Auburn research may help develop cure for children with deadly disease | 12/4/2019

… taken from them by GM1 in 2016. Porter was the first confirmed case of GM1 in Alabama. According to the National Institutes of Health (NIH) website , “GM1 gangliosidosis is an inherited disorder that progressively destroys … abortion In a trip to Montgomery, South Bend, Indiana Mayor Pete Buttigieg, a 2020 Democratic presidential candidate, visited the “National Memorial for Peace and Justice” and pledged to attempt to get black voters to finally …

Health Care Reform Articles - November 25, 2019 | 11/26/2019

… breakthroughs stem from federal investments in science – but in 2018, 43,763 out of 54,834 research project grant applications to the National Institutes of Health (NIH) were rejected. We will boost medical research by investing an … like Joseph R. Biden Jr. , the former vice president, and Pete Buttigieg , the mayor of South Bend, Ind., support adding a public health care option to the current law. While the primary race is fluid …

Sara Peerun

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act. To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-biomarkers-market-forecast-to-2029/ download_sampe_div Report Scope • Global Biomarkers Market forecasts to 2029 • This report also breaks down the revenue …

Visiongain Publishes Blood Preparation Market 2019-2029 Report | PR Newswire | 12/3/2019

… due to increasing application of blood components and rising prevalence of bleeding disorders requiring blood transfusion.• Organizations, such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), are … market To find out more about this report please contact Sara Peerun at or refer to our website: https://www.visiongain.com/report/blood-preparation-market-report-2019-2029/ Factors Restraining the Market Growth: • Risk of infection transmission …